Corporate Strategy and Business Development Director

United Therapeutics Corporation; Silver Spring (MD); Hybrid; USD 176,000 - 240,000; Full time

Job summary

United Therapeutics Corporation is seeking a Corporate Strategy & Business Development Director to identify and evaluate strategic opportunities across therapeutics, devices, and partnerships. You will lead due diligence, prepare financial analyses, and manage cross-functional deal teams.

The role requires a Master’s or PhD/MD/PharmD with extensive pharma experience, strong communication skills, and the ability to mentor staff.

Qualifications

• Master’s degree in a relevant business or scientific field with 12+ years of corporate strategy or business development experience in Pharma/Biotech.
• PhD, PharmD, or MD with 10+ years of relevant experience in Pharma/Biotech strategy and deal closures.

Responsibilities

• Identify and evaluate strategic opportunities, including acquisitions, divestitures, investments, and licensing activities.
• Lead due diligence, contract negotiations, and deal structuring with internal and external stakeholders.
• Prepare reports and presentations on financial analyses, market opportunities, and regulatory considerations.

Skills

Strategic planning

Financial analysis

Due diligence

Leadership

Communication

Education

Master’s Degree in Business or Science

PhD/MD/PharmD

Tools

Financial modeling

Job description

## Corporate Strategy and Business Development DirectorApplyremote type: Hybridlocations: RTP, NC: Silver Spring, MDtime type: Full timeposted on: Posted 3 Days Agojob requisition id: R05077California, US residents click here.**The job details are as follows:**Who We AreWe are the first publicly-traded biotech or pharmaceutical company to take the form of a public benefit corporation. Our public benefit purpose is to provide a brighter future for patients through the development of novel pharmaceutical therapies; and technologies that expand the availability of transplantable organs.United Therapeutics (Nasdaq: UTHR) seeks to travel down the corridors of indifference to develop treatments for rare, deadly diseases. We were founded in 1996 by a family seeking a cure for their daughter’s pulmonary arterial hypertension (PAH). Today, we have six FDA-approved therapies that treat PAH, pulmonary hypertension associated with interstitial lung disease (PH-ILD) and neuroblastoma, a rare pediatric cancer. Our near-term pipeline seeks to develop additional therapies for PAH and pulmonary fibrosis (PF).The cure for end-stage life-threatening diseases like PAH, PH-ILD, PF, and many others is an organ transplant, but only a small percentage of donated organs are available to address the vast need. For this reason, we are working to create manufactured organs to address the shortage of kidneys, hearts, lungs, and livers available for transplant. We believe an unlimited supply of tolerable, transplantable organs will eliminate the transplant waiting list and cure end-stage organ diseases for which transplant is not currently an option. Who You AreThe Corporate Strategy & Business Development Director is responsible for identification, evaluation, and management of the potential strategic opportunities, such as acquisitions (public and private), divestitures, equity investments, and in- and out-licensing activities, that cover all functional areas for UT including, but not limited to, small molecules, biologics and devices (drug device combinations and stand alone) for various different therapeutic areas that align with UT's mission and goals. External opportunities range in stage of development and include early-stage drug discovery and development through commercial products. This position will also manage integration of acquisitions and due diligence activities.* Identify and evaluate opportunities of potential strategic interest, including scientific validity, regulatory considerations, market opportunity, and financial analysis* Manage and coordinate discussions directly with the points of contact at the potential opportunity; lead internal and external due diligence management, contract negotiations and deal structuring* Present and provide recommendations on opportunities regarding deal structure, terms and economics based on strategic fit, market analyses and due diligence activities* Prepare reports and presentations, including overview, scientific and regulatory review and analysis, market opportunity, competition, and financial analysis, including analysis to support legal filings associated with a specific transaction* Develop financial models and perform competitive market analyses, which include financial considerations, cost structures and synergies, and cash flows* Establish, engage, and maintain relationships with internal and external experts, including UT functional areas, legal counsel, investment bankers, and other service providers* Inspire, mentor, manage and motivate staff to enhance business and financial knowledge through experience, internal exposure, collaboration, leadership, development and learning* All other duties as requiredMinimum Requirements* Master’s Degree in a relevant business or scientific field, and 12+ years of direct and relevant corporate strategy and/or business development work experience in the Pharma/Biotech space, with a track record of deal closures encompassing a wide range of structures, or* Doctor of Philosophy (PhD) in a relevant scientific field, PharmD, or MD, and 10+ years of direct and relevant corporate strategy and/or business development work experience in the Pharma/Biotech space, with a track record of deal closures encompassing a wide range of structures* Experience working in a large or mid-size pharmaceutical organization; with specific ability to grasp breadth of UT's endeavors* Ability to work independently to identify new markets, companies, and products that are strategic targets for UT* Effective communication across all levels of the organization including executive and board of directors level* Technical ability to source and evaluate financial, technical (mechanistic, preclinical and clinical data and regulatory communications), business and market data related to potential opportunities* Strong financial analysis and company/drug forecasting skills* Experience leading a team and ability to manage and motivate large cross-functional internal teams* Ability to demonstrate organizational skills and effective time-management* Ability to complete series of tasks relating to a broad range of transaction opportunities simultaneously* Outstanding written and oral communication skillsJob Location & TravelThis hybrid role can be located at either the Durham, NC office or the Silver Spring, MD office. This is a hybrid role requiring at least three days per week in the office. In office requirements could increase based on business need. This position requires up to 40% travel, which will include both domestic and international travel.The salary range for this position is $176,000 - $240,000 and reflects our good-faith estimate of the compensation for this role at the time of posting. An employee’s position within the salary range will be based on factors such as education, qualifications, experience, skills, geographic location, and business needs, as well as other factors permitted by law at the time of posting. This range may be modified in the future based on company and market factors.At United Therapeutics, our mission and vision are one. We use our enthusiasm, creativity, and persistence to innovate for the unmet medical needs of our patients and to benefit our other stakeholders. We are bold and unconventional. We have fun, we do good.Eligible employees may participate in the Company’s comprehensive benefits suite of programs, including medical / dental / vision / prescription coverage, employee wellness resources, savings plans (401k and ESPP), paid time off & paid parental leave benefits, disability benefits, and more. For additional information on Company benefits, please visit https://www.unither.com/careers/benefits-and-amenities